TR-10 AUTOPHAGY INHIBITION REVERSES RESISTANCE TO TARGETED BRAF THERAPY IN PEDIATRIC CNS TUMORS

Similar Items

• IM-01 ANTI-TUMOR EFFECT OF TRASTUZUMAB, GM-CSF AND IL-2 COMBINATORIAL THERAPY IN PEDIATRIC EPENDYMOMA
  od: Donson, Andrew, i dr.
  Izdano: (2015)
• IM-08 INFLAMMATION DRIVER, NF-kB, IS ASSOCIATED WITH POOR OUTCOME GROUP A EPENDYMOMA AND REGULATES A KEY IMMUNE SUPPRESSIVE SIGNALING PATHWAY INVOLVED IN THE TUMOR MICROENVIRONMENT
  od: Griesinger, Andrea, i dr.
  Izdano: (2015)
• EP-04 ACTIVATION OF THE IL6/STAT3 PATHWAY IN CHILDHOOD EPENDYMOMA IS ASSOCIATED WITH A PRO-INFLAMMATORY TUMOR MICROENVIRONMENT AND A POOR PROGNOSIS
  od: Griesinger, Andrea, i dr.
  Izdano: (2015)
• TR-08 TARGETED COMBINATORIAL APPROACH FOR TREATMENT OF PEDIATRIC LOW GRADE GLIOMAS IN THE CONTEXT OF BRAF(V600E) AND KIAA1549:BRAF MUTATIONS
  od: Olow, Aleksandra K., i dr.
  Izdano: (2015)
• TB-19 AUTOPHAGY INHIBITION OVERCOMES RESISTANCE TO BRAF INHIBITION IN BRAIN TUMORS
  od: Levy, Jean Mulcahy, i dr.
  Izdano: (2016)